Achieve Clinical Research commences IBS research studies
Achieve said that the research studies will enroll those already diagnosed with IBS, which includes symptoms like pain or discomfort in the abdomen, drastic change in the frequency
China-based IMPACT Therapeutics and Pharmanovia have entered an exclusive licensing deal worth up to €423.5m ($488.3m), giving Pharmanovia rights to manufacture, develop, and commercialise senaparib in 66 countries.